In our new Editor’s Pick series, EMJ Editor Sean Boyle, shares a selected article exploring biologics in non-severe asthma, including cost and patient outcomes, alignment with European health strategy and the need for early intervention.
Read more: www.emjreviews.com/allergy-immu...
In our new Editor’s Pick series, EMJ Editor Sean Boyle, shares a selected article exploring biologics in non-severe asthma, including cost and patient outcomes, alignment with European health strategy and the need for early intervention. Read more: www.emjreviews.com/allergy-immu...
0 vue
Publié le 20/08/2026 12:57
In our new Editor’s Pick series, EMJ Editor Sean Boyle, shares a selected article exploring biologics in non-severe asthma, including cost and patient outcomes, alignment with European health strategy and the need for early intervention.
Read more: www.emjreviews.com/allergy-immu...
0 commentaire
?